The diagnosis of obstructive coronary artery disease (CAD) can be challenging and relies on noninvasive imaging methods and coronary angiography. Advances in genetic technologies have enabled large-scale gene-expression studies. A gene-expression score has been shown to predict the presence of obstructive CAD.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Plasma proteomic analysis of stable coronary artery disease indicates impairment of reverse cholesterol pathway
Scientific Reports Open Access 28 June 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Change history
30 April 2013
In the version of this article originally published, the sentence "The investigators also determined that the optimal number of genes to use in their GES was 19, which had a sensitivity of 84%..." which should have been "The investigators also determined that the optimal GES threshold was 19, which had a sensitivity of 84%...". The error has been corrected in the HTML and PDF versions of the article.
References
Gibbons, R. J. et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina—summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J. Am. Coll. Cardiol. 41, 159–168 (2003).
Patel, M. R. et al. Low diagnostic yield of elective coronary angiography. N. Engl. J. Med. 362, 886–895 (2010).
Thomas, G. S. et al. A blood-based gene expression test for obstructive coronary artery disease tested in symptomatic non-diabetic patients referred for myocardial perfusion imaging: the COMPASS study. Circ. Cardiovasc. Genet. http://dx.doi.org/10.1161/CIRCGENETICS.112.964015.
Manolio, T. A. Genomewide association studies and assessment of the risk of disease. N. Engl. J. Med. 363, 166–176 (2010).
Elashoff, M. R. et al. Development of a blood-based gene expression algorithm for assessment of obstructive coronary artery disease in non-diabetic patients. BMC Med. Genomics 4, 26 (2011).
Rosenberg, S. et al. Whole blood gene expression testing for coronary artery disease innondiabetic patients: major adverse cardiovascular events and interventions in the PREDICT trial. J. Cardiovasc. Transl. Res. 5, 366–374 (2012).
Lansky, A. et al. A gender-specific blood-based gene expression score for assessing obstructive coronary artery disease in nondiabetic patients: results of the Personalized Risk Evaluation and Diagnosis in the Coronary Tree (PREDICT) trial. Am. Heart J. 164, 320–326 (2012).
Bild, D. E. et al. Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 111, 1313–1320 (2005).
Arnett, D. K. Gene expression algorithm for prevalent coronary artery disease: a first step in a long journey. Ann. Intern. Med. 153, 473–474 (2010).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Vargas, J., Lima, J. A gene-expression score to predict obstructive CAD. Nat Rev Cardiol 10, 243–244 (2013). https://doi.org/10.1038/nrcardio.2013.50
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrcardio.2013.50
This article is cited by
-
A molecular multi-gene classifier for disease diagnostics
Nature Chemistry (2018)
-
Plasma proteomic analysis of stable coronary artery disease indicates impairment of reverse cholesterol pathway
Scientific Reports (2016)
-
Correction: A gene-expression score to predict obstructive CAD
Nature Reviews Cardiology (2013)